Activist investor calls on Zevia board to sell business
Activist investor Kanen Wealth Management, which owns about 4% of Zevia, urged the board to review strategy and consider selling the US zero-sugar soft-drinks maker, citing a sale value of $2.75 to $3.75 per share versus about $1.30. Kanen criticized governance and succession. Zevia reported Q2 net sales of $45m (+1.1% YoY) and wider losses, and kept FY net sales guidance of $170m to $175m.
How this was made
The 30-second read
Why it matters
The activist’s demand for a sale review is a governance and strategic-alternatives catalyst. Zevia welcomed communication and said the board will review concerns, but no formal process or timeline is announced in the article.
Market read
Traders may reprice Zevia on activist-driven strategic alternatives risk, with potential for process headlines if the board engages or rejects the proposal.
What to watch
Zevia’s recent operating loss widening and reliance on equity-based compensation could constrain strategic options, making a sale less likely than the activist implies.
Background
Kanen Wealth Management, holding about 4% of Zevia, sent a letter (dated 14 August) urging a strategic review including a sale of the US zero-sugar stevia-sweetened beverage maker.
Ticker impact
Activist Kanen Wealth Management urges Zevia’s board to review strategy and launch a sale, valuing shares at $2.75 to $3.75 in a transaction.
Near-term volatility likely, with upside skew if investors believe a sale process is credible; downside risk if the board resists or delays.
The article discloses a concrete activist demand, ownership stake (~4%), and a stated sale valuation range, but provides no confirmed board action or formal process timeline.
Market effects
Highlights pressure on smaller beverage brands to monetize distribution and brand equity, potentially increasing M&A attention in modern soda/zero-sugar niches.
Primarily US/Canada beverage market sentiment, with potential read-through to small-cap consumer staples M&A appetite.
Limited, as the catalyst is company-specific and US-focused.
Counterpoint
The board’s response is non-committal, and the activist’s valuation range may not translate into a credible bid without financing and buyer interest.
Key entities
- public_companyZevia
US zero-sugar soft-drinks maker; shares around $1.30 at 4pm NY on Thursday; maintained full-year net sales and adjusted EBITDA loss outlook after Q2 results.
- activist_investorKanen Wealth Management
Holds around 4% of Zevia and urged the board to launch a strategy review and consider selling the business.
- investorDavid Kanen
President of Kanen Wealth Management who authored the activist letter and cited a $2.75 to $3.75 per-share sale valuation range.
- executiveAlexandre Ruberti
Appointed board member and president and CEO in June; quoted on 5 August about building a strategic plan to accelerate growth.
